132 related articles for article (PubMed ID: 23911575)
1. Bayesian inference supports a location and neighbour-dependent model of DNA methylation propagation at the MGMT gene promoter in lung tumours.
Bonello N; Sampson J; Burn J; Wilson IJ; McGrown G; Margison GP; Thorncroft M; Crossbie P; Povey AC; Santibanez-Koref M; Walters K
J Theor Biol; 2013 Nov; 336():87-95. PubMed ID: 23911575
[TBL] [Abstract][Full Text] [Related]
2. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
3. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous methylation of the O(6)-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines.
Danam RP; Howell SR; Remack JS; Brent TP
Int J Oncol; 2001 Jun; 18(6):1187-93. PubMed ID: 11351250
[TBL] [Abstract][Full Text] [Related]
5. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
7. Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer.
Smith-Sørensen B; Lind GE; Skotheim RI; Fosså SD; Fodstad Ø; Stenwig AE; Jakobsen KS; Lothe RA
Oncogene; 2002 Dec; 21(57):8878-84. PubMed ID: 12483540
[TBL] [Abstract][Full Text] [Related]
8. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T
Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440
[TBL] [Abstract][Full Text] [Related]
9. Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing.
Danam RP; Qian XC; Howell SR; Brent TP
Mol Carcinog; 1999 Feb; 24(2):85-9. PubMed ID: 10078935
[TBL] [Abstract][Full Text] [Related]
10. Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors.
Hasselblatt M; Mühlisch J; Wrede B; Kallinger B; Jeibmann A; Peters O; Kutluk T; Wolff JE; Paulus W; Frühwald MC
J Neurooncol; 2009 Jan; 91(2):151-5. PubMed ID: 18795231
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
McAleenan A; Kelly C; Spiga F; Kernohan A; Cheng HY; Dawson S; Schmidt L; Robinson T; Brandner S; Faulkner CL; Wragg C; Jefferies S; Howell A; Vale L; Higgins JPT; Kurian KM
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013316. PubMed ID: 33710615
[TBL] [Abstract][Full Text] [Related]
12. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Bady P; Sciuscio D; Diserens AC; Bloch J; van den Bent MJ; Marosi C; Dietrich PY; Weller M; Mariani L; Heppner FL; Mcdonald DR; Lacombe D; Stupp R; Delorenzi M; Hegi ME
Acta Neuropathol; 2012 Oct; 124(4):547-60. PubMed ID: 22810491
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
[TBL] [Abstract][Full Text] [Related]
14. CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.
Matsukura S; Soejima H; Nakagawachi T; Yakushiji H; Ogawa A; Fukuhara M; Miyazaki K; Nakabeppu Y; Sekiguchi M; Mukai T
Br J Cancer; 2003 Feb; 88(4):521-9. PubMed ID: 12592365
[TBL] [Abstract][Full Text] [Related]
15. O(6)-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis.
Altamura G; Strazzullo M; Corteggio A; Francioso R; Roperto F; D'Esposito M; Borzacchiello G
BMC Vet Res; 2012 Nov; 8():218. PubMed ID: 23140380
[TBL] [Abstract][Full Text] [Related]
16. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
19. MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types.
Bacolod MD; Barany F
Curr Cancer Drug Targets; 2021; 21(4):360-374. PubMed ID: 33535955
[TBL] [Abstract][Full Text] [Related]
20. The influence of methylation status on a stochastic model of MGMT dynamics in glioblastoma: Phenotypic selection can occur with and without a downshift in promoter methylation status.
Lasri A; Sturrock M
J Theor Biol; 2021 Jul; 521():110662. PubMed ID: 33684406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
